FDA Approves First Non-Opioid Painkiller in Over Two Decades
- The U.S. Food and Drug Administration approved Vertex Pharmaceuticals' Journavx, the first non-opioid painkiller in over 20 years, for short-term pain following surgery or injuries.
- Journavx provides more relief than a dummy pill but does not outperform a common opioid-acetaminophen combination pill, according to studies.
- Vertex's drug works by blocking proteins that trigger pain signals, differing from opioids that bind to brain receptors.
- Experts see promise in Journavx's unique mechanism, though its effectiveness and lengthy development process highlight challenges in pain management.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left35Leaning Right16Center107Last UpdatedBias Distribution68% Center
Bias Distribution
- 68% of the sources are Center
68% Center
L 22%
C 68%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
